The rising cost of production in Pakistan’s markets has led to a shortage of many essential medicines, including suicide prevention drugs, raising fears of a rising suicide rate in the country. Local media said this.
Referring to the formulation which is known to be the most effective medicine for the treatment, a renowned psychiatrist and former President of Pakistan Psychiatric Society (PPS) said, “There is no brand selling Lithium Carbonate available in the market since last few months , which is essential for many mental illnesses, including bipolar disorder.”
Similarly, some other essential drugs, including methylphenidate to treat Attention Deficit Hyperactivity Disorder (ADHD) in children and clonazepam drops and tablets for epilepsy in children and adults, are also not available in the market, physicians and pharmacists said.
According to The News, several other psychiatrists from the Pakistan Institute of Medical Sciences (PIMS), Shifa International Hospital Islamabad and Mayo Hospital Lahore, as well as psychiatrists from Peshawar, confirmed that relatives of patients suffering from bipolar disorder were able to find lithium carbonate. Tried a lot, but none of its brands were available in the market.
Iqbal Afridi Said, “There Are Some Alternatives to This Drug, But They Are Not As Effective As Lithium Carbonate.”
He said that pharmaceutical companies and the Drug Regulatory Authority of Pakistan (DRAP) have been requested to ensure the availability of this drug as there are hundreds of patients with the disease.
Pakistan Pharmaceutical Manufacturers Association (PPMA) President Qazi Mansoor Dilawar conceded that many drugs were not available in the local market, as their production costs had increased to an extent where it was not viable for manufacturers to produce the drugs and they had to cost less to produce. sell at a lower price.
Qazi Mansoor Dilawar said, “The devaluation of the rupee is the biggest factor in the rising cost of producing many essential medicines.
Raw material costs are rising, while utilities, transportation and other costs have made it easier for pharmaceutical companies to manufacture many essential medicines. made impossible.”